AxoGen (AXGN) News Today $14.16 +0.15 (+1.07%) Closing price 04:00 PM EasternExtended Trading$14.00 -0.15 (-1.09%) As of 05:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AXGN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Axogen: Broad Range Of Outcomes Still Present, Opting To Remain SidelinedAugust 12 at 6:01 AM | seekingalpha.comIBD Rating Upgrades: Axogen Shows Improved Price StrengthAugust 11 at 10:35 PM | msn.comAxoGen (NASDAQ:AXGN) Upgraded to Buy at Wall Street ZenAugust 10 at 2:56 AM | marketbeat.comFY2025 EPS Estimates for AxoGen Lifted by Cantor FitzgeraldAugust 9 at 10:26 AM | marketbeat.comCantor Fitzgerald Brokers Lift Earnings Estimates for AxoGenAugust 9 at 3:37 AM | americanbankingnews.comAxoGen (AXGN) Gets a Buy from Leerink PartnersAugust 9 at 2:24 AM | theglobeandmail.comAxogen (AXGN) Q2 Revenue Jumps 18%August 9 at 2:24 AM | theglobeandmail.comAxoGen (NASDAQ:AXGN) Upgraded by Wall Street Zen to "Buy" RatingAugust 9 at 2:59 AM | americanbankingnews.comAxoGen price target lowered to $20 from $21 at Raymond JamesAugust 6, 2025 | msn.comAxoGen (NASDAQ:AXGN) Shares Gap Up - Here's What HappenedAugust 6, 2025 | marketbeat.comAxogen, Inc. (AXGN) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comAxogen, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.comAxoGen Q2 2025 Earnings PreviewAugust 4, 2025 | msn.comAxoGen (NASDAQ:AXGN) Trading Up 5.4% - Here's WhyJuly 30, 2025 | marketbeat.comAxoGen (AXGN) Expected to Announce Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comAxoGen exploring possible sale after approach, Street Insider saysJuly 30, 2025 | msn.comAxogen gains on report of takeover interestJuly 30, 2025 | msn.comAxoGen (NASDAQ:AXGN) Sees Strong Trading Volume - Should You Buy?July 29, 2025 | marketbeat.comAxogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth ConferenceJuly 29, 2025 | globenewswire.comGSA Capital Partners LLP Raises Stake in AxoGen, Inc. (NASDAQ:AXGN)July 29, 2025 | marketbeat.comAxogen, Inc. to report 2025 second quarter financial results on August 5, 2025July 22, 2025 | globenewswire.comAxoGen (NASDAQ:AXGN) Trading Up 8% - Here's What HappenedJuly 22, 2025 | marketbeat.comHussman Strategic Advisors Inc. Increases Position in AxoGen, Inc. (NASDAQ:AXGN)July 19, 2025 | marketbeat.comLeerink Partnrs Has Pessimistic View of AxoGen Q2 EarningsJuly 17, 2025 | marketbeat.comLeerink Partnrs Estimates AxoGen's Q4 Earnings (NASDAQ:AXGN)July 16, 2025 | marketbeat.comAxoGen’s SWOT analysis: nerve repair leader’s stock poised for growthJuly 8, 2025 | investing.comHighMark Wealth Management LLC Has $661,000 Stake in AxoGen, Inc. (NASDAQ:AXGN)June 27, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Receives Average Recommendation of "Buy" from AnalystsJune 25, 2025 | marketbeat.comAdvisor Resource Council Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN)June 21, 2025 | marketbeat.comAssenagon Asset Management S.A. Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)June 14, 2025 | marketbeat.comCantor Fitzgerald Reaffirms Their Buy Rating on AxoGen (AXGN)June 5, 2025 | theglobeandmail.comAxoGen, Inc. (NASDAQ:AXGN) Short Interest UpdateJune 4, 2025 | marketbeat.comCantor Fitzgerald Analysts Cut Earnings Estimates for AxoGenJune 4, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Squarepoint Ops LLCJune 2, 2025 | marketbeat.comMillennium Management LLC Lowers Position in AxoGen, Inc. (NASDAQ:AXGN)June 2, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Receives Consensus Rating of "Buy" from BrokeragesJune 1, 2025 | marketbeat.comJane Street Group LLC Sells 30,670 Shares of AxoGen, Inc. (NASDAQ:AXGN)June 1, 2025 | marketbeat.comAxogen, Inc to Participate at Goldman Sachs Global Healthcare ConferenceMay 28, 2025 | globenewswire.comBank of America Corp DE Reduces Stake in AxoGen, Inc. (NASDAQ:AXGN)May 28, 2025 | marketbeat.comAmeriprise Financial Inc. Has $4.81 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)May 26, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Director Joseph A. Tyndall Sells 20,062 SharesMay 24, 2025 | insidertrades.comAxoGen, Inc. (NASDAQ:AXGN) is Soleus Capital Management L.P.'s 7th Largest PositionMay 21, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN)May 19, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Sells 146,038 Shares of AxoGen, Inc. (NASDAQ:AXGN)May 18, 2025 | marketbeat.comCubist Systematic Strategies LLC Sells 101,445 Shares of AxoGen, Inc. (NASDAQ:AXGN)May 18, 2025 | marketbeat.comAxoGen, Inc. (NASDAQ:AXGN) Position Lessened by Parkman Healthcare Partners LLCMay 16, 2025 | marketbeat.comNicholas Investment Partners LP Has $4.87 Million Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)May 16, 2025 | marketbeat.comWhat Analysts Are Saying About Axogen StockMay 15, 2025 | nasdaq.comAxoGen (NASDAQ:AXGN) Price Target Lowered to $24.00 at Canaccord Genuity GroupMay 15, 2025 | marketbeat.comAxoGen FY2025 EPS Estimate Reduced by Cantor FitzgeraldMay 15, 2025 | marketbeat.com Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address AXGN Media Mentions By Week AXGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXGN News Sentiment▼0.440.75▲Average Medical News Sentiment AXGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXGN Articles This Week▼174▲AXGN Articles Average Week Get AxoGen News Delivered to You Automatically Sign up to receive the latest news and ratings for AXGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LIVN News EYE News LMAT News CNMD News LQDA News ENOV News AORT News CDRE News NVCR News SSII News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AXGN) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredElon Musk: “Nothing happens without this…”Lithium has fueled the EV boom, but another resource is even more critical. Without it, over 20 million electr...Behind the Markets | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AxoGen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AxoGen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access